JHL 2.27% 4.5¢ jayex healthcare limited

Ann: Appendix 4E and 2017 Annual Report, page-6

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 26 Posts.
    lightbulb Created with Sketch. 12
    As you mentioned ItGuru, zero relevant experience and vision.
    The company can't manage integration of technology since 2015 (2 and a half years) that it 100% owns but the company tries to sell innovation? It doesn't matter how much lipstick you put on the pig, it's still a ...

    "2017 was a challenging year for Jayex, as the company faced on-going difficulties with the integration of the Appointuit product into the other Group technologies, which resulted in the operational and financial results falling behind"
    Directors' report, 31 December 2017
    from the same report...
    "changes that the company made in 2017 will support the digital transformation in healthcare and revolutionise patient care in new and exciting ways. Our healthcare solutions will be delivered on our modern and innovative healthcare platform."
 
watchlist Created with Sketch. Add JHL (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.